Skip to content
AnalystLens

Somnigroup International 8-K Report, Regulation FD Disclosure (Nov 7, 2024)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed November 7, 2024
Period End
November 7, 2024
Security
SGI
In the record · 2016–202610-K1110-Q328-K220

SGI filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 220 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’18Mar ’18
  2. Material agreement8-K · May ’20May ’20
  3. Leadership change8-K · Jul ’22Jul ’22
  4. Deal closed8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed November 7, 2024. Cited figures are marked; the original filing is the authoritative source.

Tempur Sealy International, Inc. (TPX), now Somnigroup International (SGI), furnished an updated investor presentation on November 7, 2024 under Item 7.01 (Regulation FD Disclosure) as Exhibit 99.1.

The presentation is intended for use in meetings with investors and is furnished, not filed, for purposes of Section 18 of the Exchange Act. The presentation reiterates the company's positioning as a leading global bedding company with brands including Tempur-Pedic, Sealy and Stearns & Foster, sold through third-party retailers, 750+ company-owned stores and e-commerce. For the trailing twelve months ended September 30, 2024, it reports net sales of $4,893.5 milliona, net income of $389.5 million, adjusted EBITDA of $906.8 million and GAAP EPS of $2.19.

For the third quarter of 2024, net sales were $1,300.0 millionb, up 1.8%, and adjusted EPS was $0.82, up 6.5%. The presentation's 2024 outlook calls for sales slightly below the prior year, adjusted EBITDA of approximately $915 million at the midpoint and full-year adjusted EPS between $2.45 and $2.55. It also details the pending acquisition of Mattress Firm for a total purchase price of approximately $4.0 billion ($2.7 billion cash and $1.3 billion stock), expected to close in late 2024 or early 2025, with net leverage estimated at 3.0x-3.25x at closing.

Key Highlights

  1. Q3 2024 net sales of $1,300.0 million, up 1.8% from $1,277.1 million in Q3 2023; GAAP EPS of $0.82 vs. $0.77 adjusted EPS (presented as adjusted EPS of $0.82, up 6.5%)
  2. TTM September 30, 2024 net sales of $4,893.5 million, adjusted EBITDA of $906.8 million and adjusted EPS of $2.48
  3. 2024 outlook: sales slightly below prior year, adjusted EBITDA of approximately $915 million at midpoint, and full-year adjusted EPS of $2.45 to $2.55
  4. Pending Mattress Firm acquisition with total purchase price of approximately $4.0 billion, including $2.7 billion cash and $1.3 billion stock (34.2M shares issued at $37.62)
  5. Mattress Firm pro forma ownership of 83.4% for TPX shareholders and 16.6% for Mattress Firm shareholders; expected to be accretive to adjusted EPS in Year 1 with $100 million of cost synergies by Year 4
  6. Net leverage expected at 3.0x-3.25x at closing, with a return to the 2.0x-3.0x target range within the first twelve months after closing
  7. Industry outlook: anticipates U.S. produced mattress units down high single digits in 2024; company credit ratings include BB+ (Fitch), Ba1 (Moody's) and BB (S&P)

Frequently Asked Questions

  1. What did Tempur Sealy disclose in this 8-K filing?

    The company furnished an updated investor presentation dated November 7, 2024 as Exhibit 99.1, under Item 7.01 (Regulation FD Disclosure). The presentation will be used from time to time in investor meetings and is furnished rather than filed for Exchange Act Section 18 purposes.

  2. What are the company's 2024 financial expectations?

    The presentation expects 2024 sales slightly below the prior year, adjusted EBITDA of approximately $915 million at the midpoint, and full-year adjusted EPS between $2.45 and $2.55. It also assumes diluted share count of 179 million, D&A of $200 million to $205 million, capital expenditures of approximately $125 million and interest expense of $125 million to $130 million.

  3. What is the Mattress Firm transaction?

    The company has agreed to acquire Mattress Firm, the largest U.S. mattress specialty retailer, for a total purchase price of approximately $4.0 billion, comprising $2.7 billion of cash and $1.3 billion of stock. The deal is expected to close in late 2024 or early 2025, subject to customary conditions and regulatory approvals, and is expected to be accretive to adjusted EPS in Year 1.

  4. How has the company performed recently?

    For the third quarter of 2024, net sales were $1,300.0 million compared with $1,277.1 million a year earlier, net income was $130.0 million versus $113.3 million, and adjusted EBITDA was $274.8 million versus $259.7 million. Direct channel sales represented 24% of Q3 2024 sales.

  5. How does the company describe its balance sheet and capital allocation?

    The company cites over $1 billion of liquidity, favorable borrowing rates and no meaningful debt maturities until 2028. Its long-term target leverage ratio is 2.0x to 3.0x, and it pursues a quarterly dividend, opportunistic share repurchases and strategic acquisitions. The leverage ratio was 2.41 times as of September 30, 2024 on a consolidated indebtedness basis.